Bank of America
SLXNW

Bank of America’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Bank of America’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$3 – 7066
2025
Q4 		$3 Hold
100
– – ﹤0.01% 7254
2025
Q3 		$4 Hold
100
– – ﹤0.01% 8255
2025
Q2 		$4 Sell
100
-10
-9% -$1 ﹤0.01% 8335
2025
Q1 		$8 Sell
110
-155
-58% -$9 ﹤0.01% 8221
2024
Q4 		$9 Buy
265
+165
+165% +$7 ﹤0.01% 8096
2024
Q3 		$3 Buy
+100
New +$6 ﹤0.01% 8110

Other funds holding SLXNW

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return

Bank of America's SLXNW Position: Q1 2026 in Review

Bank of America sold out of Silexion Therapeutics Warrant (SLXNW) in Q1 2026, closing a stake of 100 shares — an estimated $3 sold.

Bank of America first reported a position in SLXNW in Q3 2024 and held it in 6 quarters. The position peaked at $9 in Q4 2024. 19 funds tracked by Wall St. Rank hold SLXNW as of Q1 2026.

  • Bank of America reported no remaining Silexion Therapeutics Warrant position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 100 Silexion Therapeutics Warrant shares in Q1 2026, an estimated $3.
  • Bank of America first reported a position in Silexion Therapeutics Warrant in Q3 2024 and held it in 6 quarters.
  • Bank of America's Silexion Therapeutics Warrant position peaked at $9 in Q4 2024.
  • 19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.